Empirical Finance’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.87M | Sell |
42,134
-76
| -0.2% | -$10.6K | 0.28% | 80 |
|
|
2025
Q4 | $5.18M | Sell |
42,210
-1,869
| -4% | -$227K | 0.25% | 79 |
|
|
2025
Q3 | $4.89M | Buy |
44,079
+415
| +1% | +$47.2K | 0.23% | 91 |
|
|
2025
Q2 | $4.84M | Buy |
43,664
+277
| +0.6% | +$29.5K | 0.25% | 79 |
|
|
2025
Q1 | $4.86M | Buy |
43,387
+641
| +1% | +$66.1K | 0.29% | 72 |
|
|
2024
Q4 | $3.95M | Sell |
42,746
-578
| -1% | -$52K | 0.23% | 83 |
|
|
2024
Q3 | $3.63M | Buy |
43,324
+928
| +2% | +$70.8K | 0.21% | 96 |
|
|
2024
Q2 | $2.91M | Sell |
42,396
-3,051
| -7% | -$204K | 0.18% | 106 |
|
|
2024
Q1 | $3.33M | Buy |
45,447
+1,527
| +3% | +$117K | 0.2% | 106 |
|
|
2023
Q4 | $3.56M | Buy |
43,920
+211
| +0.5% | +$16.4K | 0.25% | 90 |
|
|
2023
Q3 | $3.28M | Buy |
43,709
+4,410
| +11% | +$339K | 0.24% | 91 |
|
|
2023
Q2 | $3.03M | Buy |
39,299
+4,297
| +12% | +$343K | 0.23% | 91 |
|
|
2023
Q1 | $2.9M | Buy |
35,002
+1,712
| +5% | +$142K | 0.27% | 79 |
|
|
2022
Q4 | $2.86M | Buy |
33,290
+2,679
| +9% | +$212K | 0.3% | 74 |
|
|
2022
Q3 | $1.89M | Buy |
30,611
+4,952
| +19% | +$312K | 0.22% | 85 |
|
|
2022
Q2 | $1.59M | Buy |
25,659
+1,367
| +6% | +$84.6K | 0.2% | 93 |
|
|
2022
Q1 | $1.44M | Buy |
24,292
+2,672
| +12% | +$171K | 0.16% | 116 |
|
|
2021
Q4 | $1.57M | Buy |
21,620
+5,737
| +36% | +$395K | 0.19% | 101 |
|
|
2021
Q3 | $1.11M | Sell |
15,883
-7,950
| -33% | -$559K | 0.17% | 122 |
|
|
2021
Q2 | $1.64M | Sell |
23,833
-4,921
| -17% | -$329K | 0.27% | 75 |
|
|
2021
Q1 | $1.68M | Hold |
28,754
| – | – | 0.29% | 93 |
|
|
2020
Q4 | $1.68M | Buy |
28,754
+2,234
| +8% | +$135K | 0.29% | 93 |
|
|
2020
Q3 | $1.68M | Buy |
26,520
+1,924
| +8% | +$133K | 0.36% | 71 |
|
|
2020
Q2 | $1.89M | Buy |
24,596
+1,481
| +6% | +$114K | 0.48% | 41 |
|
|
2020
Q1 | $1.73M | Sell |
23,115
-12,045
| -34% | -$832K | 0.54% | 37 |
|
|
2019
Q4 | $2.29M | Sell |
35,160
-2,251
| -6% | -$147K | 0.56% | 23 |
|
|
2019
Q3 | $2.37M | Sell |
37,411
-678
| -2% | -$44.3K | 0.66% | 19 |
|
|
2019
Q2 | $2.57M | Buy |
38,089
+247
| +0.7% | +$16.2K | 0.71% | 21 |
|
|
2019
Q1 | $2.46M | Buy |
37,842
+1,550
| +4% | +$103K | 0.63% | 22 |
|
|
2018
Q4 | $2.27M | Sell |
36,292
-270
| -0.7% | -$18.9K | 0.67% | 22 |
|
|
2018
Q3 | $2.82M | Buy |
36,562
+20,749
| +131% | +$1.57M | 0.7% | 17 |
|
|
2018
Q2 | $1.12M | Sell |
15,813
-22,029
| -58% | -$1.56M | 0.28% | 69 |
|
|
2018
Q1 | $2.46M | Buy |
37,842
+23,592
| +166% | +$1.88M | 0.63% | 22 |
|
|
2017
Q4 | $1.02M | Sell |
14,250
-19,144
| -57% | -$1.45M | 0.34% | 81 |
|
|
2017
Q3 | $2.71M | Buy |
33,394
+5,178
| +18% | +$396K | 0.93% | 13 |
|
|
2017
Q2 | $2M | Buy |
28,216
+800
| +3% | +$53.2K | 0.77% | 20 |
|
|
2017
Q1 | $1.86M | Buy |
27,416
+13,253
| +94% | +$932K | 0.87% | 23 |
|
|
2016
Q4 | $1.01M | Buy |
+14,163
| New | +$1.05M | 0.68% | 38 |
|
Other funds holding GILD
VCM
VPM
Empirical Finance's GILD Position: Q1 2026 in Review
Empirical Finance reduced its Gilead Sciences (GILD) stake by 0.18% in Q1 2026, selling an estimated $10.6K and leaving 42,134 shares worth $5.87M. The position accounts for 0.28% of the portfolio, ranked #80.
Empirical Finance first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Empirical Finance held 42,134 shares of Gilead Sciences worth $5.87M as of Q1 2026.
- Empirical Finance sold 76 Gilead Sciences shares in Q1 2026, an estimated $10.6K.
- Gilead Sciences made up 0.28% of Empirical Finance's portfolio in Q1 2026, its #80 holding.
- Empirical Finance first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Empirical Finance's 13F filing for Q1 2026, filed 14 May 2026.